OTSUKA PHARMACEUTICAL CO., LTD. et al v. ACCORD HEALTHCARE INC. et al > Summary
Court Case Number 1:19-cv-01072
Filing Date Oct 18, 2019
Termination Date Mar 9, 2020
Court North Carolina Middle District Court
Status Dismissed - Voluntarily
Plaintiff Attorneys
4Otsuka Pharmaceutical
Attorney Name: Allison Mullins
Turning Point Litigation | Mullins Duncan Harrell & Russell
Otsuka Pharmaceutical
Attorney Name: Stephen McDaniel Russell Jr.
Turning Point Litigation | Mullins Duncan Harrell & Russell
H. Lundbeck A/S
Attorney Name: Allison Mullins
Turning Point Litigation | Mullins Duncan Harrell & Russell
H. Lundbeck A/S
Attorney Name: Stephen McDaniel Russell Jr.
Turning Point Litigation | Mullins Duncan Harrell & Russell
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10307419 | Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof | Jun 4, 2019 |
09839637 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 12, 2017 |
08618109 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 31, 2013 |
08349840 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jan 8, 2013 |
07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |